Endoscopic Quality Improvement Program (EQUIP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01415817|
Recruitment Status : Completed
First Posted : August 12, 2011
Last Update Posted : August 12, 2011
|Condition or disease||Intervention/treatment||Phase|
|Adenomatous Polyps Colorectal Polyps||Other: Training session||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||15 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Effect of an Intensive Endoscopic Quality Improvement Program (EQUIP) on Improved Detection and Classification of Non-polypoid (Flat and Depressed) and Polypoid Colorectal Adenomas. ("EQUIP" Study)|
|Study Start Date :||August 2010|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||April 2011|
|No Intervention: Baseline Data collection|
|Experimental: Randomization and Training Arm||
Other: Training session
Series of two training sessions after the first phase of study followed by monthly feedback.
- Measurement of overall adenoma detection rate [ Time Frame: 1 year ]Primary outcome measures will include overall and per patient adenoma detection rate for polypoid and non polypoid neoplastic lesions.
- Measurement of total polypectomy rate [ Time Frame: 1 Year ]Secondary outcomes will include total polypectomy rate (hyperplastic vs. adenoma),
- Measurement of colonoscopy time [ Time Frame: 1 Year ]Total colonoscopy time and endoscopist acceptance. Variables such as patient demographics and prep quality will be adjusted for.
- Endoscopist Acceptance [ Time Frame: 1 Year ]Ensdoscopist acceptance rate will be measured. Variables such as patient demographics and prep quality will be adjusted for.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01415817
|United States, Florida|
|Mayo Clinic Florida|
|Jacksonville, Florida, United States, 32224|
|Principal Investigator:||Michael B. Wallace, MD,MPH||Mayo Clinic Florida|